Contractor
KINIKSA PHARMACEUTICALS (UK), LTD.
LONDON
- UEI
- HBHWNLNMHSV5
- Parent UEI
- R9NLFGW24EB1
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$68,0451
Awards
3
Agencies served
1
Active from Oct 25, 2021 to Oct 6, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36F79722D0002 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | — | Oct 25, 2021 | — |
| 36C24526N0595 ARCALYST 220 MG | Department of Veterans Affairs | — | May 21, 2026 | $34,023 |
| 36C24526N0418 ARCALYST 200 MG | Department of Veterans Affairs | — | Mar 18, 2026 | $34,023 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier HBHWNLNMHSV5, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.